Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
Clinical trial NCT05536154 · UNKNOWN
Trial details
- NCT number
- NCT05536154
- Sponsor
- The Affiliated People's Hospital of Ningbo University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2024-06-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.